Search
for

    Sort by

    Research 421–450 of 1000+

    1. Additive Effects of Platelet-Rich Plasma and Systemic Therapies in Androgenetic Alopecia: A Retrospective Study Skin Appendage Disorders · 2026
    2. NANOCARRIER-BASED DELIVERY OF MINOXIDIL: CURRENT PERSPECTIVES AND FUTURE DIRECTIONS IN ALOPECIA THERAPY Zenodo (CERN European Organization for Nuclear Research) · 2026
    3. NANOCARRIER-BASED DELIVERY OF MINOXIDIL: CURRENT PERSPECTIVES AND FUTURE DIRECTIONS IN ALOPECIA THERAPY Zenodo (CERN European Organization for Nuclear Research) · 2026
    4. Persistent chemotherapy-induced alopecia: updates in diagnosis and treatment persistent chemotherapy induced alopecia: an updated approach Actas Dermo-Sifiliográficas · 2026
    5. Characterization and Management of Androgenetic Alopecia in Transgender and Gender-Diverse Individuals: A Narrative Review Dermatology and Therapy · 2026
    6. Systemic treatment options for androgenic alopecia Lithuanian University of Health Sciences · 2026
    7. Quality of Life in Polycystic Ovary Syndrome after Anti-Androgen Therapy Using PCOSQOL-47 and PCOSQOL-42 Endocrine Metabolic & Immune Disorders - Drug Targets · 2026
    8. Prescribing Habits for Androgenetic Alopecia among Dermatologists in Spain in 2024: A Cross-Sectional Study Actas Dermo-Sifiliográficas · 2026
    9. Female pattern hair loss PubMed Central · 2026
    10. Androgenetic Alopecia in Women: A Narrative Review of Pathophysiology, Clinical Evaluation, and Treatments American Journal of Clinical Dermatology · 2026
    11. Alopecia Feminina De Origem Endócrina: Abordagem Integrativa Editora Pasteur eBooks · 2026
    12. ANDROGENETIC ALOPECIA: A REVIEW OF CURRENT THERAPEUTIC OPTIONS International Journal of Innovative Technologies in Social Science · 2025
    13. Novel Synthetic Steroid Derivatives: Target Prediction and Biological Evaluation of Antiandrogenic Activity Current Issues in Molecular Biology · 2025
    14. Role of Anti-Androgens in the Management of Polycystic Ovary Syndrome (PCOS) Zenodo (CERN European Organization for Nuclear Research) · 2025
    15. Role of Anti-Androgens in the Management of Polycystic Ovary Syndrome (PCOS) Zenodo (CERN European Organization for Nuclear Research) · 2025
    16. Polycystic Ovary Syndrome-Associated Acne: The Interplay of Hyperandrogenism, Insulin Resistance, and Therapeutic Strategies Cureus · 2025
    17. Farmácia Boa Hora - Porto Open Repository of the University of Porto (University of Porto) · 2025
    18. Cyproterone acetate for hirsutism Cochrane Database of Systematic Reviews · 2025
    19. NUMERICAL DESCRIPTOR COMPUTATION OF ALOPECIA DRUGS USING COM – POLYNOMIAL International Journal of Apllied Mathematics · 2025
    20. Uso do espironolactona no tratamento da acne vulgar na mulher adulta: uma revisão integrativa Saúde (Santa Maria) · 2025
    21. SUN-118 A Case of Anastrozole Induced Hyperandrogenism Journal of the Endocrine Society · 2025
    22. SYSTEMATIC REVIEW OF PHARMACOTHERAPY STRATEGIES IN THE MANAGEMENT OF HIDRADENITIS SUPPURATIVA International Journal of Innovative Technologies in Social Science · 2025
    23. Should Oral Minoxidil be Our First Choice for Treatment of Alopecia? International Journal of Trichology · 2025
    24. Management of adolescent polycystic ovary syndrome Journal of Association of Clinical Endocrinologist and Diabetologist of Bangladesh · 2025
    25. Androgenetic Alopecia: An Update on Pathogenesis and Pharmacological Treatment Drug Design Development and Therapy · 2025
    26. What is the treatment for hair loss in women? Zenodo (CERN European Organization for Nuclear Research) · 2025
    27. What is the treatment for hair loss in women? Zenodo (CERN European Organization for Nuclear Research) · 2025
    28. Cancer-Related Alopecia Risk and Treatment Current Treatment Options in Oncology · 2025
    29. Safety of Alopecia Treatments in Patients with Breast Cancer and High-Risk Women: A Review American Journal of Clinical Dermatology · 2025
    30. Update From Dermatology Nurses’ Association Convention 2025 Journal of the Dermatology Nurses’ Association · 2025